HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Qixin Wang Selected Research

olverembatinib

1/2022FLT3 inhibition by olverembatinib (HQP1351) downregulates MCL-1 and synergizes with BCL-2 inhibitor lisaftoclax (APG-2575) in preclinical models of FLT3-ITD mutant acute myeloid leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Qixin Wang Research Topics

Disease

6Neoplasms (Cancer)
07/2022 - 11/2019
4COVID-19
02/2022 - 05/2020
4Pneumonia (Pneumonitis)
11/2021 - 05/2020
4Fibrosis (Cirrhosis)
08/2021 - 12/2014
4Heart Failure
08/2021 - 01/2018
3Chronic Obstructive Pulmonary Disease (COPD)
01/2022 - 10/2019
3Myocardial Infarction
08/2021 - 01/2018
2Inflammation (Inflammations)
02/2022 - 01/2020
2Lung Diseases (Lung Disease)
01/2022 - 12/2020
2Emphysema
01/2022 - 01/2021
2Cardiomegaly (Heart Hypertrophy)
08/2021 - 12/2014
2Lung Injury
06/2020 - 06/2020
2Respiratory Tract Diseases (Respiratory Tract Disease)
01/2020 - 02/2008
2Chronic Hepatitis B
05/2019 - 10/2016
2Hyperplasia
01/2016 - 08/2014
1Lung Neoplasms (Lung Cancer)
03/2022
1Breast Neoplasms (Breast Cancer)
03/2022
1Organizing Pneumonia
03/2022
1Neoplasm Metastasis (Metastasis)
03/2022
1Malaria
02/2022
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2022
1Leukemia
01/2022
1Mitochondrial Diseases (Mitochondrial Disease)
11/2021
1Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell)
09/2021
1Lymphoma (Lymphomas)
08/2021
1Metabolic Diseases (Metabolic Disease)
05/2021
1Plasmacytoma
01/2021
1Alzheimer Disease (Alzheimer's Disease)
01/2021
1Airway Remodeling
10/2019
1Hypertrophy
12/2014
1Atherosclerosis
01/2014
1Stroke (Strokes)
03/2010

Drug/Important Bio-Agent (IBA)

4Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
03/2022 - 08/2021
4CytokinesIBA
06/2020 - 01/2019
3Proteins (Proteins, Gene)FDA Link
03/2022 - 06/2020
368Ga-FAPIIBA
03/2022 - 01/2021
3SmokeIBA
01/2022 - 01/2021
3NicotineFDA Link
06/2020 - 10/2019
2Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
07/2022 - 08/2021
2Baoyuan decoctionIBA
08/2021 - 04/2020
2Biomarkers (Surrogate Marker)IBA
05/2021 - 01/2020
2AerosolsIBA
12/2020 - 10/2019
2Triglycerides (Triacylglycerol)IBA
06/2020 - 06/2020
2Vitamin EFDA LinkGeneric
06/2020 - 06/2020
2Acetates (Acetic Acid Esters)FDA Link
06/2020 - 06/2020
2LipidsIBA
01/2020 - 01/2014
2Hepatitis B e AntigensIBA
05/2019 - 10/2016
2Valsartan (Vals)FDA Link
01/2016 - 08/2014
1ErbB Receptors (EGF Receptor)IBA
07/2022
1trametinibIBA
07/2022
1Tyrosine Kinase InhibitorsIBA
07/2022
1Aldehyde DehydrogenaseIBA
07/2022
1Drug CombinationsIBA
07/2022
1MitogensIBA
07/2022
1Tetrazolium SaltsIBA
07/2022
1Carboplatin (JM8)FDA LinkGeneric
07/2022
1Paclitaxel (Taxol)FDA LinkGeneric
07/2022
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
07/2022
1osimertinibIBA
07/2022
1artemisinin (artemisinine)IBA
02/2022
1Pharmaceutical PreparationsIBA
02/2022
1STAT5 Transcription FactorIBA
01/2022
1LisaftoclaxIBA
01/2022
1olverembatinibIBA
01/2022
1GTP Phosphohydrolases (GTPases)IBA
11/2021
1GATA Transcription FactorsIBA
08/2021
1Carrier Proteins (Binding Protein)IBA
08/2021
1FlavonoidsIBA
01/2021
1quinolineIBA
01/2021
1heme receptorIBA
01/2021
1pembrolizumabIBA
11/2019
1Immune Checkpoint InhibitorsIBA
11/2019
1InterferonsIBA
05/2019
1qishen granuleIBA
01/2019
1p38 Mitogen-Activated Protein KinasesIBA
01/2018
1peginterferon alfa-2b (Pegintron)FDA Link
10/2016
1Hepatitis B Surface Antigens (HBsAg)FDA Link
10/2016
1Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
01/2016
1Hydrogen Sulfide (Sulfide, Hydrogen)IBA
12/2014
1CollagenIBA
12/2014
1Endothelins (Endothelin)IBA
12/2014
1sodium bisulfide (NaHS)IBA
12/2014
1salicylhydroxamic acid (SHAM)IBA
12/2014
1Hydroxyproline (4 Hydroxyproline)IBA
12/2014
1Angiotensin IIIBA
08/2014
1Type 1 Angiotensin ReceptorIBA
08/2014
1Scavenger Receptors (Scavenger Receptor)IBA
01/2014
1Rosuvastatin Calcium (Crestor)FDA Link
01/2014
1Phosphates (Orthophosphate)IBA
03/2010
1Adenosine Triphosphate (ATP)IBA
03/2010
1Nitrogen OxidesIBA
02/2008
1Environmental Pollutants (Pollutants, Environmental)IBA
02/2008
1Air Pollutants (Pollutants, Air)IBA
02/2008
1Sulfur DioxideIBA
02/2008
1Particulate MatterIBA
02/2008
1Carbon MonoxideIBA
02/2008

Therapy/Procedure

7Therapeutics
07/2022 - 10/2016
1Chinese Traditional Medicine (Traditional Chinese Medicine)
02/2022
1Intraperitoneal Injections
12/2014